A detailed history of Data Collective Iv Gp, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 3,875 shares of ROIV stock, worth $49,173. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,875
Previous 3,875 -0.0%
Holding current value
$49,173
Previous $40,000 10.0%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$6.92 - $9.98 $151,997 - $219,210
-21,965 Reduced 85.0%
3,875 $28,000
Q4 2022

Feb 14, 2023

BUY
$3.36 - $7.99 $86,822 - $206,461
25,840 New
25,840 $206,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.94B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Data Collective Iv Gp, LLC Portfolio

Follow Data Collective Iv Gp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Data Collective Iv Gp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Data Collective Iv Gp, LLC with notifications on news.